NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient
Sallman, David A, Brayer, Jason, Sagatys, Elizabeth M, Lonez, Caroline, Breman, Eytan, Agaugué, Sophie, Verma, Bikash, Gilham, David E, Lehmann, Frédéric F, Davila, Marco L
Published in Haematologica (Roma) (01.09.2018)
Published in Haematologica (Roma) (01.09.2018)
Get full text
Journal Article
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma
Logue, Jennifer M., Peres, Lauren C., Hashmi, Hamza, Colin-Leitzinger, Christelle M., Shrewsbury, Alexandria M., Hosoya, Hitomi, Gonzalez, Rebecca M., Copponex, Christina, Kottra, Krista H., Hovanky, Vanna, Sahaf, Bita, Patil, Sunita, Lazaryan, Aleksandr, Jain, Michael D., Baluch, Aliyah, Klinkova, Olga V., Bejanyan, Nelli, Faramand, Rawan G., Elmariah, Hany, Khimani, Farhad, Davila, Marco L., Mishra, Asmita, Blue, Brandon J., Grajales-Cruz, Ariel F., Castaneda Puglianini, Omar A., Liu, Hien D., Nishihori, Taiga, Freeman, Ciara L., Brayer, Jason B., Shain, Kenneth H., Baz, Rachid C., Locke, Frederick L., Alsina, Melissa, Sidana, Surbhi, Hansen, Doris K.
Published in Blood advances (27.12.2022)
Published in Blood advances (27.12.2022)
Get full text
Journal Article
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
Sallman, David A, Kerre, Tessa, Havelange, Violaine, Poiré, Xavier, Lewalle, Philippe, Wang, Eunice S, Brayer, Jason B, Davila, Marco L, Moors, Ine, Machiels, Jean-Pascal, Awada, Ahmad, Alcantar-Orozco, Erik M, Borissova, Rossitza, Braun, Nathalie, Dheur, Marie-Sophie, Gilham, David E, Lonez, Caroline, Lehmann, Frédéric F, Flament, Anne
Published in The Lancet. Haematology (01.03.2023)
Published in The Lancet. Haematology (01.03.2023)
Get more information
Journal Article
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types
Lonez, Caroline, Verma, Bikash, Hendlisz, Alain, Aftimos, Philippe, Awada, Ahmad, Van Den Neste, Eric, Catala, Gaetan, Machiels, Jean-Pascal H, Piette, Fanny, Brayer, Jason B, Sallman, David A, Kerre, Tessa, Odunsi, Kunle, Davila, Marco L, Gilham, David E, Lehmann, Frédéric F
Published in BMJ open (01.11.2017)
Published in BMJ open (01.11.2017)
Get full text
Journal Article
A Single-Arm, Open-Label Phase 2 Pilot Study of Vyxeos (CPX-351) in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia
Shah, Bijal D., Rozario, Nicole, Turba, Elyce P., Bello, Celeste, Chavez, Julio C., Sokol, Lubomir, Brayer, Jason, Lancet, Jeffrey E.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Daratumumab Based Response Adapted Therapy for Older Adults with Newly Diagnosed Multiple Myeloma: Interim Analysis of Phase II Study
Baz, Rachid C., Kim, Jongphil, Sam, Christine, Blue, Brandon J., Toska, Sonila, Collier, Aaron, Brayer, Jason, Grajales-Cruz, Ariel F, Alsina, Melissa, Siqueira Silva, Ariosto, Shain, Kenneth H.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Immune Profiles of Myeloma Tumor Microenvironment May Predict Sensitivity or Resistance to Elotuzumab
Noyes, David, Alsina, Melissa, Shain, Kenneth H., Baz, Rachid, Nishihori, Taiga, Ochoa, Jose, Song, Jinming, Kim, Jongphil, Achille, Alexandra, Brayer, Jason
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma
Freeman, Ciara L, Atkins, Reginald, Varadarajan, Indumathy, Menges, Meghan, Edelman, Jeffrey, Baz, Rachid, Brayer, Jason, Castaneda Puglianini, Omar, Ochoa-Bayona, Jose Leonel, Nishihori, Taiga, Shain, Kenneth H, Shah, Bijal, Chen, Dung Tsa, Kelley, Linda, Coppola, Domenico, Alsina, Melissa, Antonia, Scott, Anasetti, Claudio, Locke, Frederick L
Published in Clinical cancer research (14.11.2023)
Published in Clinical cancer research (14.11.2023)
Get full text
Journal Article
Similar Benefits of High-Dose Melphalan Based Conditioning Regimens Followed By Autologous Hematopoietic Cell Transplantation in Elderly Myeloma Population Compared to the Younger Group: Single Center Experience
Nishihori, Taiga, Freeman, Ciara L., Hansen, Doris K., Blue, Brandon J., Castaneda Puglianini, Omar Alexis, Kim, Jongphil, Grajales-Cruz, Ariel F., Brayer, Jason, Ochoa, Jose, Liu, Hien D., Shain, Kenneth H., Baz, Rachid C., Locke, Frederick L., Alsina, Melissa
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Comparing Outcomes of Outpatient Vs. Inpatient High-Dose Melphalan Based Conditioning Regimens Followed By Autologous Hematopoietic Cell Transplantation in Myeloma
Nishihori, Taiga, Hansen, Doris K., Liu, Hien D., Castaneda Puglianini, Omar Alexis, Freeman, Ciara L., Blue, Brandon J., Brayer, Jason, Kim, Jongphil, Grajales-Cruz, Ariel F, Ochoa, Jose, Baz, Rachid C., Shain, Kenneth H., Locke, Frederick L., Alsina, Melissa
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Patterns of Relapse and Clinical Outcomes in Multiple Myeloma Patients after Anti-BCMA CAR T-Cell Therapy: Implications for Patient's Monitoring after CAR T-Cell Therapy
Castaneda Puglianini, Omar Alexis, Peres, Lauren C., Hansen, Doris K., Nishihori, Taiga, Grajales-Cruz, Ariel F, Blue, Brandon J., Brayer, Jason, Freeman, Ciara L., Shain, Kenneth H., Liu, Hien D., Ochoa, Jose, Locke, Frederick L., Baz, Rachid C., Alsina, Melissa
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome with REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 First-in-Human Study in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Zonder, Jeffrey A., Richter, Joshua, Bumma, Naresh, Brayer, Jason, Hoffman, James E, Bensinger, William I., Wu, Ka Lung, Xu, Linzhi, Chokshi, Dhruti, Boyapati, Anita, Sharma, Manish, Rodriguez Lorenc, Karen, Kroog, Glenn S, Dhodapkar, Madhav V, Lentzsch, Suzanne, Cooper, Dennis, Jagannath, Sundar
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Immunicy-1: Targeting BCMA with Cyad-211 to Establish Proof of Concept of an shRNA-Based Allogeneic CAR T Cell Therapy Platform
Al-Homsi, Ahmad-Samer, Anguille, Sebastien, Deeren, Dries, Nishihori, Taiga, Meuleman, Nathalie, Abdul-Hay, Maher, Morgan, Gareth J., Brayer, Jason, Braun, Nathalie, Lonez, Caroline, Dheur, Marie-Sophie, Alcantar-Orozco, Erik, Gilham, David, Flament, Anne, Lehmann, Frédéric F.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience
Ionescu, Filip, Patel, Parth, Thapa, Shrinjaya, Drekolias, Dimitrios, Blue, Brandon Jamaal, Castaneda Puglianini, Omar Alexis, Ochoa-Bayona, Jose L., Freeman, Ciara L., Liu, Hien, Hansen, Doris K., Nishihori, Taiga, Silva, Ariosto, Sudalagunta, Praneeth Reddy, Brayer, Jason B., Alsina, Melissa, Shain, Kenneth H., Baz, Rachid C., Grajales-Cruz, Ariel Felipe
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article